Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Update on treatment advances in combined-modality therapy for anal and rectal carcinomas.

Publication ,  Journal Article
Meyer, J; Balch, G; Willett, C; Czito, B
Published in: Curr Oncol Rep
June 2011

Concurrent radiation therapy and chemotherapy is the primary treatment for patients with squamous cell tumors of the anal canal, and is also employed in the neoadjuvant setting for patients with stage II and III adenocarcinoma of the rectum. There is constant clinical study involving modifications of chemoradiotherapy regimens in an effort to maximize tumor responses while reducing normal tissue toxicity. This review will discuss established regimens as well as newer and novel treatment approaches to treatment of anal and rectal cancer.

Duke Scholars

Published In

Curr Oncol Rep

DOI

EISSN

1534-6269

Publication Date

June 2011

Volume

13

Issue

3

Start / End Page

177 / 185

Location

United States

Related Subject Headings

  • Rectal Neoplasms
  • Oxaliplatin
  • Organoplatinum Compounds
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Neoadjuvant Therapy
  • Mitomycin
  • Humans
  • Combined Modality Therapy
  • Clinical Trials as Topic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Meyer, J., Balch, G., Willett, C., & Czito, B. (2011). Update on treatment advances in combined-modality therapy for anal and rectal carcinomas. Curr Oncol Rep, 13(3), 177–185. https://doi.org/10.1007/s11912-011-0166-z
Meyer, Jeffrey, Glen Balch, Christopher Willett, and Brian Czito. “Update on treatment advances in combined-modality therapy for anal and rectal carcinomas.Curr Oncol Rep 13, no. 3 (June 2011): 177–85. https://doi.org/10.1007/s11912-011-0166-z.
Meyer J, Balch G, Willett C, Czito B. Update on treatment advances in combined-modality therapy for anal and rectal carcinomas. Curr Oncol Rep. 2011 Jun;13(3):177–85.
Meyer, Jeffrey, et al. “Update on treatment advances in combined-modality therapy for anal and rectal carcinomas.Curr Oncol Rep, vol. 13, no. 3, June 2011, pp. 177–85. Pubmed, doi:10.1007/s11912-011-0166-z.
Meyer J, Balch G, Willett C, Czito B. Update on treatment advances in combined-modality therapy for anal and rectal carcinomas. Curr Oncol Rep. 2011 Jun;13(3):177–185.
Journal cover image

Published In

Curr Oncol Rep

DOI

EISSN

1534-6269

Publication Date

June 2011

Volume

13

Issue

3

Start / End Page

177 / 185

Location

United States

Related Subject Headings

  • Rectal Neoplasms
  • Oxaliplatin
  • Organoplatinum Compounds
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Neoadjuvant Therapy
  • Mitomycin
  • Humans
  • Combined Modality Therapy
  • Clinical Trials as Topic